XML 69 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES              
Net loss $ (14,416,081) $ (11,872,886) $ (20,823,603) $ (2,533,544) $ (43,317,640) $ (26,804,394)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Amortization of debt discount 1,567,677       2,090,236 817,118  
Amortization of capitalized software         177,926 36,001  
Amortization of intangibles         340,457 251,709  
Write-down of inventory         57,481  
Depreciation of fixed assets         2,865  
Acceleration of debt discount         500,145  
Bad debt expense         58,470  
Sales return and allowances         211,000  
Inventory reserves         44,981  
Gain on forgiveness of debt         (184,914)  
Operating lease payments         73,767 5,452  
Liability to issue shares for services         32,500  
Stock issued for services         35,200  
Stock compensation expense         7,983,891 16,898,733  
Changes in assets and liabilities              
Accounts receivable         (848,766) (586,364)  
Product deposit         (95,183) (943,388)  
Inventory         (380,317) (953,467)  
Other current assets         (534,479) 72,893  
Change in operating lease liability         (68,085) (1,737)  
Deferred revenue         519,101 303,064  
Accounts payable and accrued expenses         6,924,110 4,426,702  
Net cash used in operating activities         (27,259,550) (5,595,382)  
CASH FLOWS FROM INVESTING ACTIVITIES              
Cash paid for capitalized software costs         (1,731,507) (330,586)  
Purchase of equipment         (70,105)  
Purchase of intangible assets         (22,231)  
Payment to seller for contingent consideration         (400,000)  
Net cash used in investing activities         (1,823,843) (730,586)  
CASH FLOWS FROM FINANCING ACTIVITIES              
Cash proceeds from private placement offering, net         13,495,270  
Cash proceeds from Series B Preferred Stock         2,892,500  
Proceeds from convertible notes payable         2,350,000  
Proceeds from issuance of debt instruments         15,000,000  
Cash proceeds from sale of common stock under ATM         493,481 2,338,349  
Cash proceeds from exercise of warrants         480,609 622,763  
Cash proceeds from exercise of options         820,750 300,400  
Cash proceeds from sale of warrants         25,000  
Purchase of membership interest of WorkSimpli         (300,000)  
Distributions to non-controlling interest (36,000)   0   (108,000) (121,223)  
Proceeds from notes payable         963,965 242,000  
Repayment of notes payable         (1,494,784) (2,498,808)  
Debt issuance costs         (15,000)  
Net cash provided by financing activities         29,351,291 6,135,981  
Net increase (decrease) in cash         267,898 (189,987)  
Cash at beginning of period   $ 9,179,075   1,106,624 9,179,075 1,106,624 $ 1,106,624
Cash at end of period $ 9,446,973   $ 916,637   9,446,973 916,637 $ 9,179,075
Cash paid for interest              
Cash paid during the period for interest         120,062 592,961  
Non-cash investing and financing activities              
Cashless exercise of options         8,730  
Cashless exercise of warrants       49,551  
Principal of Paycheck Protection Program loans forgiven         184,914  
Additional purchase of membership interest in WorkSimpli issued in performance options         144,002  
Deemed dividend from warrant price adjustments         1,216,021  
Deemed distribution from warrants issued with Series B Preferred Stock         3,500,000  
Warrants issued for debt instruments         6,270,710  
Stock yet to be issued for capitalized costs         40,000  
Deemed distribution from down-round provision on unissued shares         194,022  
Liability to issue common stock         76,348  
Debt issuance costs for liability to issue shares         219,450  
Conversion of convertible notes payable and interest for Series B Preferred Stock         607,500  
Stock issued for capitalized costs         $ 12,675